These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 22535962)

  • 1. New class of HIV-1 integrase (IN) inhibitors with a dual mode of action.
    Tsiang M; Jones GS; Niedziela-Majka A; Kan E; Lansdon EB; Huang W; Hung M; Samuel D; Novikov N; Xu Y; Mitchell M; Guo H; Babaoglu K; Liu X; Geleziunas R; Sakowicz R
    J Biol Chem; 2012 Jun; 287(25):21189-203. PubMed ID: 22535962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization.
    Christ F; Shaw S; Demeulemeester J; Desimmie BA; Marchand A; Butler S; Smets W; Chaltin P; Westby M; Debyser Z; Pickford C
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4365-74. PubMed ID: 22664975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.
    Christ F; Debyser Z
    Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors.
    Kessl JJ; Jena N; Koh Y; Taskent-Sezgin H; Slaughter A; Feng L; de Silva S; Wu L; Le Grice SF; Engelman A; Fuchs JR; Kvaratskhelia M
    J Biol Chem; 2012 May; 287(20):16801-11. PubMed ID: 22437836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage.
    Le Rouzic E; Bonnard D; Chasset S; Bruneau JM; Chevreuil F; Le Strat F; Nguyen J; Beauvoir R; Amadori C; Brias J; Vomscheid S; Eiler S; Lévy N; Delelis O; Deprez E; Saïb A; Zamborlini A; Emiliani S; Ruff M; Ledoussal B; Moreau F; Benarous R
    Retrovirology; 2013 Nov; 10():144. PubMed ID: 24261564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinoline-based Protein-protein Interaction Inhibitors of LEDGF/p75 and HIV Integrase: An In Silico Study.
    Chhokar N; Kalra S; Chauhan M; Munshi A; Kumar R
    Curr Top Med Chem; 2018; 18(32):2800-2815. PubMed ID: 30747071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cells.
    Balakrishnan M; Yant SR; Tsai L; O'Sullivan C; Bam RA; Tsai A; Niedziela-Majka A; Stray KM; Sakowicz R; Cihlar T
    PLoS One; 2013; 8(9):e74163. PubMed ID: 24040198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs.
    Schrijvers R; De Rijck J; Demeulemeester J; Adachi N; Vets S; Ronen K; Christ F; Bushman FD; Debyser Z; Gijsbers R
    PLoS Pathog; 2012; 8(3):e1002558. PubMed ID: 22396646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design of LEDGINs as first allosteric integrase inhibitors for the treatment of HIV infection.
    Desimmie BA; Demeulemeester J; Christ F; Debyser Z
    Drug Discov Today Technol; 2013 Dec; 10(4):e517-22. PubMed ID: 24451643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication.
    Christ F; Voet A; Marchand A; Nicolet S; Desimmie BA; Marchand D; Bardiot D; Van der Veken NJ; Van Remoortel B; Strelkov SV; De Maeyer M; Chaltin P; Debyser Z
    Nat Chem Biol; 2010 Jun; 6(6):442-8. PubMed ID: 20473303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation.
    Jurado KA; Wang H; Slaughter A; Feng L; Kessl JJ; Koh Y; Wang W; Ballandras-Colas A; Patel PA; Fuchs JR; Kvaratskhelia M; Engelman A
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8690-5. PubMed ID: 23610442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host factors for retroviral integration site selection.
    Debyser Z; Christ F; De Rijck J; Gijsbers R
    Trends Biochem Sci; 2015 Feb; 40(2):108-16. PubMed ID: 25555456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LEDGIN-mediated Inhibition of Integrase-LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV.
    Vranckx LS; Demeulemeester J; Saleh S; Boll A; Vansant G; Schrijvers R; Weydert C; Battivelli E; Verdin E; Cereseto A; Christ F; Gijsbers R; Debyser Z
    EBioMedicine; 2016 Jun; 8():248-264. PubMed ID: 27428435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based virtual screening toward the discovery of novel inhibitors for impeding the protein-protein interaction between HIV-1 integrase and human lens epithelium-derived growth factor (LEDGF/p75).
    Panwar U; Singh SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3199-3217. PubMed ID: 28948865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome.
    van Bel N; van der Velden Y; Bonnard D; Le Rouzic E; Das AT; Benarous R; Berkhout B
    PLoS One; 2014; 9(7):e103552. PubMed ID: 25072705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of host nucleoporin 62 in HIV-1 integrase chromatin association and viral DNA integration.
    Ao Z; Jayappa KD; Wang B; Zheng Y; Wang X; Peng J; Yao X
    J Biol Chem; 2012 Mar; 287(13):10544-10555. PubMed ID: 22308026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LEDGINs, Inhibitors of the Interaction Between HIV-1 Integrase and LEDGF/p75, Are Potent Antivirals with a Potential to Cure HIV Infection.
    Debyser Z; Bruggemans A; Van Belle S; Janssens J; Christ F
    Adv Exp Med Biol; 2021; 1322():97-114. PubMed ID: 34258738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,2,3,4-Tetrahydroisoquinolines as inhibitors of HIV-1 integrase and human LEDGF/p75 interaction.
    George A; Gopi Krishna Reddy A; Satyanarayana G; Raghavendra NK
    Chem Biol Drug Des; 2018 Jun; 91(6):1133-1140. PubMed ID: 29405651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity.
    Amadori C; van der Velden YU; Bonnard D; Orlov I; van Bel N; Le Rouzic E; Miralles L; Brias J; Chevreuil F; Spehner D; Chasset S; Ledoussal B; Mayr L; Moreau F; García F; Gatell J; Zamborlini A; Emiliani S; Ruff M; Klaholz BP; Moog C; Berkhout B; Plana M; Benarous R
    Retrovirology; 2017 Nov; 14(1):50. PubMed ID: 29121950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric inhibition of human immunodeficiency virus integrase: late block during viral replication and abnormal multimerization involving specific protein domains.
    Gupta K; Brady T; Dyer BM; Malani N; Hwang Y; Male F; Nolte RT; Wang L; Velthuisen E; Jeffrey J; Van Duyne GD; Bushman FD
    J Biol Chem; 2014 Jul; 289(30):20477-88. PubMed ID: 24904063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.